期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

三阴乳腺癌的特点及治疗进展

Clinical characteristics and treatment progress of triple-negative breast cancer
原文传递
导出
摘要 三阴性乳腺癌（TNBC）是具有独特的病理和分子生物学特征的乳腺癌亚型。该类型表现为复发早、进展快、预后差等特点。手术、放疗、化疗是目前主要治疗手段。近年来随着研究不断深入，新的化疗药物及靶向药物正逐步应用于临床。 Triple-negative breast cancer （TNBC） is a subtype of breast cancers which have exclusive pathological and molecular biological characteristics. TNBC＇s chief feature is early recurrence, rapidly progres- sive and poor prognosis. Operation, chemotherapy and radiotherapy are the major therapies for TNBC. In recent years, with the developing of the research, new chemotherapeutic drugs and targeted therapies are applied to clinical therapy gradually.
作者 高会全 马学真
机构地区 青岛大学医学院解放军第 青岛大学医学院附属二院肿瘤科
出处 《国际肿瘤学杂志》 CAS 2013年第1期25-28,共4页 Journal of International Oncology
关键词 乳腺肿瘤 预后 治疗 Breast neoplasms Prognosis Therapy
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献18

  • 1de Ruijter TC,Veeck J,de Hoon JP. Characteristics of triplenegative breast cancer[J].Journal of Cancer Research and Clinical Oncology,2011,(02):183-192.
  • 2Niwi(n)ska A,Olszewski W,Murawska M. Triple-negative breast cancer with brain metastases:a comparison between basal-like and non-basal-like biological subtypes[J].Journal of Neuro-Oncology,2011,(03):547-553.
  • 3Bertucci F,Finetti P,Cervera N. How basal are triple-negative breast cancers[J].International Journal of Cancer,2008,(01):236-240.
  • 4Cheang MC,Voduc D,Bajdik C. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triplenegative phenotype[J].Clinical Cancer Research,2008,(05):1368-1376.
  • 5Meyer P,Landgraf K,H(o)gel B. BRCA2 mutations and triplenegative breast cancer[J].PLoS One,2012,(05):e38361.
  • 6Chu QD,Henderson AE,Ampil F. Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity[J].Int J Breast Cancer,2012.764570.
  • 7Chen XS,Ma CD,Wu JY. Molecular subtype approximated by quantitative estrogen receptor,progesterone receptor and Her2 can predict the prognosis of breast cancer[J].Tumori,2010,(01):103-110.
  • 8Dent R,Trudeau M,Pritchard KI. Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clinical Cancer Research,2007,(15 Ptl):4429-4434.
  • 9Solin LJ,Hwang WT,Vapiwala N. Outcome after breast conservation treatment with radiation for women with triple-negative earlystage invasive breast carcinoma[J].Clinical Breast Cancer,2009,(02):96-100.
  • 10Wang S,Yang H,Tong F. Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer[J].Gan To Kaqaku Ryoho,2009,(02):255-258.

二级参考文献11

  • 1Cleator S,Heller W,Coombes RC.Triple-negative breast cancer:Therapeutic options[J].Lancet Oncol,2007,8(3):235.
  • 2Eneman JD,Wood ME,Muss HB.Selecting adjuvant endocrine therapy for breast cancer[J].Oncology,2004,18(14):1733-1744.
  • 3Michaud LB.Treatment-experienced breast cancer[J].Am J Health Syst Pharm,2008,65(10 Suppl 3):4-9.
  • 4Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumors[J].Nature,2000,406:747-752.
  • 5Kreike B,van Kouwenhove M,Horlings H,et al.Gene expression profiling and histopathological characterization of triple negative/basal-like breast carcinomas[J].Breast Cancer Res,2007,9:65.
  • 6Blackstein M,Vogel CL,Ambinder R,et al.Gemcitabine as firsfline thempy in patients with metastatic breast cancer:a phase Ⅱ trial[J].Oncology,2002,62(1):2-8.
  • 7Brodowicz T,Kostler WJ,Moslinger R,et al.Single-agent gemeitabine as second-line and third-line treatment in metastatic breast cancer[J].Breast,2000,9(6):338-342.
  • 8Bhattacharyya A,Ear US,Koler BH,et al.The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin[J].J Biol Chem,2000,275(31):23899.
  • 9Chitanarux I,Lorvidhara V,Kamnerdsupaphon P,et al.Cemcitabine plus cisplatin(GC):a salvage regimen for advanced breast cancer patients who have failed anthracycline and/or taxane therapy[J].Gan To Kagaku Ryoho,2006,33(6):761.
  • 10Lin NU,Bellon JR,Winer EP.CNS metastases in breast cancer[J].Clin Oncol,2004,22:3608-1317.

共引文献12

国际肿瘤学杂志
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部